Cofactors

Natural Products in Chemical Biology

Volumn , Issue , 2012, Pages 239-267

  Haase, Ilka ^a   Fischer, Markus ^a   Bacher, Adelbert ^b   Eisenreich, Wolfgang ^b   Rohdich, Felix ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Auto heterotrophic organisms and coenzymes; Biosynthesis of isoprenoid type cofactors; Branched, coenzyme biosynthesis pathways and drug interaction; Microorganisms and novel coenzymes, in cofactor biosynthesis; Specific biosynthetic pathways, pantothenate biosynthesis

Indexed keywords

EID: 84886148538     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118391815.ch10     Document Type: Chapter

References (82)

1. Leeper FJ, Smith AG. Editorial: vitamins and cofactors-chemistry, biochemistry and biology. Nat. Prod. Rep. 2007;24:923-926.
2. Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem. J. 2000;347:1-16.
3. Scott IA. Discovering nature's diverse pathways to vitamin B12: a 35-year odyssey. J. Org. Chem. 2003;68:2529-2539.
4. Roth JR, Lawrence JG, Bobik TA. Cobalamin (coenzyme B12): synthesis and biological significance. Annu. Rev. Microbiol. 1996;50:137-181.
5. Taga ME, Larsen NA, Howard-Jones AR, Walsh CT, Walker GC. BluB cannibalizes flavin to form the lower ligand of vitamin B12. Nature 2007;446:449-453.
6. Brown KL. Chemistry and enzymology of vitamin B12. Chem. Rev. 2005;105: 2075-2149.
7. Rebeille F, Ravanel S, Marquet A, Mendel RR, Smith AG, Warrene MJ. Roles of vitamins B5, B8, B9, B12 and molybdenum cofactor at cellular and organismal levels. Nat. Prod. Rep. 2007;24:949-962.
8. Mendel RR. Biology of the molybdenum cofactor. J. Exp. Bot. 2007;58:2289-2296
9. Raschle T, Arigoni D, Brunisholz R, Rechsteiner H, Amrhein N, Fitzpatrick TB. Reaction mechanism of pyridoxal 5'-phosphate synthase. Detection of an enzymebound chromophoric intermediate. J. Biol. Chem. 2007;282:6098-6105.
10. Johnson DC, Dean DR, Smith AD, Johnson MK. Structure, function and formation of biological iron-sulfur clusters. Annu. Rev. Biochem. 2005;74:247-281.
11. Imlay JA. Iron-sulphur clusters and the problem with oxygen. Mol. Microbiol. 2006;59:1073-1082.
12. Kessler D. Enzymatic activation of sulfur for incorporation into biomolecules in prokaryotes. FEMS Microbiol. Rev. 2006;30:825-840.
13. Lill R, Müehlenhoff U. Iron-sulfur protein biogenesis in eukaryotes: components and mechanisms. Annu. Rev. Cell Dev. Biol. 2006;22:457-486.
14. Leeper FJ. The biosynthesis of porphyrins, chlorophylls, and vitamin B12. Nat. Prod. Rep. 1989;6:171-203.
15. Holliday GL, Thornton JM, Marquet A, Smith AG, Rebeillé F, Mendel RR, Schubert HL, Lawrence AD, Warren MJ. Evolution of enzymes and pathways for the biosynthesis of cofactors. Nat. Prod. Rep. 2007;24:972-987.
16. Panek H, O'Brian MR. A whole genome view of prokaryotic haem biosynthesis. Microbiology 2002;148(Pt 8): 2273-2282.
17. Tanaka R, Tanaka A. Tetrapyrrole biosynthesis in higher plants. Annu. Rev. Plant Biol. 2007;58:321-346.
18. Mendel RR, Smith AG, Marquet A, Warren MJ. Metal and cofactor insertion. Nat. Prod. Rep. 2007;24:963-971.
19. Warren MJ, Scott AI. Tetrapyrrole assembly and modification into the ligands of biologically functional cofactors. Trends Biochem. Sci. 1990;15:486-491.
20. Webb ME, Marquet A, Mendel RR, Rebeille F, Smith AG. Elucidating biosynthetic pathways for vitamins and cofactors. Nat. Prod. Rep. 2007;24:988-1008.
21. Roje S. Vitamin B biosynthesis in plants. Phytochem 2007;68:1904-1921.
22. Bacher A, Fischer M. Biosynthesis of flavocoenzymes. Nat. Prod. Rep. 2005;22: 324-350.
23. Begley TP. Cofactor biosynthesis: an organic chemist's treasure trove. Nat. Prod. Rev. 2006;23:15-25.
24. Chatterjee A, Jurgenson CT, Schroeder FC, Ealick SE, Begley TP. Biosynthesis of thiamin thiazole in eukaryotes: conversion of NAD to an advanced intermediate. J. Am. Chem. Soc. 2007;129:2914-2922.
25. Raschke M, Bürkle L, Müller N, Nunes-Nesi A, Fernie AR, Arigoni D, Amrhein N, Fitzpatrick TB. Vitamin B1 biosynthesis in plants requires the essential iron sulfur cluster protein, THIC. Proc. Natl. Acad. Sci. U.S.A. 2007;104:19637-19642.
26. Fitzpatrick TB, Amrhein N, Kappes B, Macheroux P, Tews I. Two independent routes of de novo vitamin B6 biosynthesis: not that different after all. Biochem. J. 2007;407:1-13.
27. Scott DE, Ciulli, Abell C. Coenzyme biosynthesis: enzyme mechanism, structure and inhibition. Nat. Prod. Rep. 2007;24:1009-1026.
28. Ehrenshaft M, Bilski P, Li MY, Chignell CF, Daub ME. A highly conserved sequence is a novel gene involved in de novo vitamin B6 biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 1999;96:9374-9378.
29. Osmani AH, May GS, Osmani SA. The extremely conserved pyroA gene of Aspergillus nidulans is required for pyridoxine synthesis and is required indirectly for resistance to photosensitizers. J. Biol. Chem. 1999;274:23565-23569.
30. Tambasco-Studart M, Titiz O, Raschle T, Forster G, Amrhein N, Fitzpatrick TB. Vitamin B6 biosynthesis in higher plants. Proc. Natl. Acad. Sci. U.S.A. 2005;102: 13687-13692.
31. Denu JM. Vitamins and aging: pathways to NAD+ synthesis. Cell. 2007;129: 453-454.
32. Belenky P, Racette FG, Bogan KL, McClure JM, Smith JS, Brenner C. Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Cell. 2007;129:473-484.
33. Begley TP, Kinsland C, Mehl RA, Osterman A, Dorrestein P. The biosynthesis of nicotinamide adenine dinucleotides in bacteria. Vitam. Horm. 2001;61:103-119.
34. Webb ME, Smith AG, Abell C. Biosynthesis of pantothenate. Nat. Prod. Rep. 2004;21:695-721.
35. Chakauya E, Coxona KM, Whitney HM, Ashurst JL, Abell C, Smith AG. Pantothenate biosynthesis in higher plants: advances and challenges. Physiol. Plant. 2006;126:319-329.
36. Linster CL, Van Schaftingen E. Vitamin C: Biosynthesis, recycling and degradation in mammals. FEBS J. 2007;274:1-22.
37. Smirnoff N. L-ascorbic acid biosynthesis. Vitam. Horm. 2001;61:241-266.
38. Wheeler GL, Jones MA, Smirnoff, N. The biosynthetic pathway of vitamin C in higher plants. Nature 1998;393:365-369.
39. Linster CL, Gomez TA, Christensen KC, Young BD, Brenner C. Arabidopsis VTC2 encodes a GDP-L-galactose phosphorylase, the last unknown enzyme in the Smirnoff- Wheeler pathway to ascorbic acid in plants. J. Biol. Chem. 2007;282:18879-18885.
40. Davidson VL. Electron transfer in quinoproteins. Arch. Biochem. Biophys. 2004; 428:32-40.
41. Felton LM, Anthony C. Role of PQQ as a mammalian enzyme cofactor? Nature 2005;433:E10.
42. Kasahara T, Kato T. A new redox-cofactor vitamin for mammals. Nature 2003;422:832.
43. Rucker, R, Storms, D, Sheets, A, Tchaparian, E and Fascetti, A. Is pyrroloquinoline quinone a vitamin? Nature. 2005;433:E10-E11.
44. Magnusson OT, Toyama H, Saeki M, Schwarzenbacher R, Klinman JP. The structure of a biosynthetic intermediate of pyrroloquinoline quinone (PQQ) and elucidation of the final step of PQQ biosynthesis. J. Am. Chem. Soc. 2004;126:5342-5343.
45. Magnusson OT, Toyama H, Saeki M, Rojas A, Reed JC, Liddington RC, Klinman JP, Schwarzenbacher R. Quinone biogenesis: Structure and mechanism of PqqC, the final catalyst in the production of pyrroloquinoline quinone. Proc. Natl. Acad. Sci. U.S.A. 2004;101:7913-7918
46. Marquet A, Bui BT. Biosynthesis of biotin and lipoic acid. Vitam. Horm. 2001; 61:51-101.
47. Marquet A, Tse Sum Bui, B, Smith AG, Warren MJ. Iron-sulfur proteins as initiators of radical chemistry. Nat. Prod. Rep. 2007;24:1027-1040.
48. Sacchettini JC, Poulter CD. Creating isoprenoid diversity. Science 1997;277: 1788-1789.
49. Slater, EE and MacDonald, JS. Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative. Drugs 1988;36 Suppl 3: 72-82.
50. Stancu C, Sima A. Statins: mechanism of action and effects. J. Cell. Mol. Med. 2001;5:378-387.
51. Qureshi N, Porter JW. Conversion of acetyl-coenzyme A to isopentenyl pyrophosphate. In: Biosynthesis of Isoprenoid Compounds. J. W. Porter and S. L. Spurgeon, eds. 1981. John Wiley, New York. pp. 47-94.
52. Eisenreich W, Bacher A, Arigoni D, Rohdich F. Biosynthesis of isoprenoids via the non-mevalonate pathway. Cell. Mol. Life Sci. 2004;61:1401-1426.
53. Siemieniuk E, Skrzydlewska E. Coenzyme Q10: its biosynthesis and biological significance in animal organisms and in humans. Postepy. Hig. Med. Dosw. 2005;59:150-159.
54. Szkopiñska A, Ubiquinone. Biosynthesis of quinone ring and its isoprenoid side chain. Intracellular localization. Acta Biochim. Polonica. 2000;47:469-480.
55. Graham DE, White RH. Elucidation of methanogenic coenzyme biosyntheses: from spectroscopy to genomics. Nat. Prod. Rep. 2002;19:133-147.
56. Eisenreich W, Schwarzkopf B, Bacher A. Biosynthesis of nucleotides, flavins, and deazaflavins in Methanobacterium thermoautotrophicum. J. Biol. Chem. 1991;266:9622-9631.
57. Reuke B, Korn S, Eisenreich W, Bacher A. Biosynthetic precursors of deazaflavins. J. Bacteriol. 1992;174:4042-4049.
58. Grochowski LL, Xu H, Leung K, White RH. Characterization of an Fe2+-dependent archaeal-specific GTP cyclohydrolase, MptA, from Methanocaldococcus jannaschii. Biochemistry 2007;46:6658-6667.
59. Koetter JW, Schulz GE. Crystal structure of 6-hydroxy-D-nicotine oxidase from Arthrobacter nicotinovorans. J. Mol. Biol. 2005;352:418-428.
60. Jitrapakdee S, Wallace JC. The biotin enzyme family: conserved structural motifs and domain rearrangements. Curr. Protein Pept. Sci. 2003;4:217-229.
61. Rucker RB, Wold F. Cofactors in and as posttranslational protein modifications. FASEB J. 1988;2:2252-2261.
62. Vagelos PR, Majerus PW, Alberts AW, Larrabee AR, Ailhaud GP. Structure and function of the acyl carrier protein. Fed. Proc. 1966;25:1485-1494.
63. Blair-Johnson M, Fiedler T, Fenna R. Human myeloperoxidase: structure of a cyanide complex and its interaction with bromide and thiocyanate substrates at 1.9 A resolution. Biochemistry 2001;40:13990-13997.
64. Singh AK, Singh N, Sharma S, Singh SB, Kaur P, Bhushan A, Srinivasan A, Singh TP. Crystal structure of Lactoperoxidase at 2.4 A resolution. J. Mol. Biol. 2007;376:1060-1075.
65. Furtmüller PG, Zederbauer M, Jantschko W, Helm J, Bogner M, Jakopitsch C, Obinger C. Active site structure and catalytic mechanisms of human peroxidases. Arch. Biochem. Biophys. 2006;445:199-213.
66. Davidson VL. Protein-derived cofactors. Expanding the scope of post-translational modifications. Biochemistry 2007;46:5283-5292.
67. Fischer M, Bacher A. Biosynthesis of vitamin B2 in plants. Physiol. Plant. 2006;126: 304-318.
68. Ralph SA, van Dooren GG, Waller RF, Crawford MJ, Fraunholz, MJ, Foth, BJ, Tonkin, CJ, Roos, DS and McFadden, GI. Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol. 2004;2:203-216.
69. van Dooren GG, Stimmler LM, McFadden GI. Metabolic maps and functions of the Plasmodium mitochondrion. FEMS Microbiol. Rev. 2006;30:596-630.
70. Smith AG, Croft MT, Moulin M, Webb ME. Plants need their vitamins too. Curr. Op. Plant Biol. 2007;10:266-275.
71. Muntau AC, Röschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff CP, Roscher AA. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N. Engl. J. Med. 2002;347:2122-3212.
72. Tahiliani AG, Beinlich CJ. Pantothenic acid in health and disease. Vitam. Horm. 1991;46:165-228.
73. Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, Gitschier J. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N. Engl. J. Med. 2003;348:33-40.
74. Schwarz G. Molybdenum cofactor biosynthesis and deficiency. Cell Mol. Life Sci. 2005;62:2792-2810.
75. Sarkany RP. Porphyria. From Sir Walter Raleigh to molecular biology. Adv. Exp. Med. Biol. 1999;455:235-241.
76. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N. Engl. J. Med. 1997;337: 1441-1448.
77. Lange RP, Locher HH, Wyss PC, Then RL. The targets of currently used antibacterial agents: lessons for drug discovery. Curr. Pharm. Des. 2007;13:3140-3154.
78. Wiesner J, Ortmann R, Jomaa H, Schlitzer M. New antimalarial drugs. Angew. Chem. Int. Ed. Engl. 2003;42:5274-5293.
79. Gangjee A, Jain HD. Antifolates-past, present and future. Curr. Med. Chem. Anticancer Agents. 2004;4:405-410.
80. Mazighi M, Lavallee PC, Labreuche J, Amarenco P. Statin therapy and stroke prevention: what was known, what is new and what is next? Curr. Opin. Lipidol. 2007;18:622-625.
81. Harper CR, Jacobson TA. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr. Opin. Lipidol. 2007;18:401-408.
82. Holick MF. Vitamin D deficiency. N. Engl. J. Med. 2007;357:266-281.